* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID Gene_Symbol DisGeNet_diseaseID Disease_name DisGeNet score DisGeNet_sourceDB
672BRCA1C0006142Malignant neoplasm of breast0.64BEFREE;GAD;MGD;ORPHANET;UNIPROT
672BRCA1C2676676BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 10.6CTD_human;ORPHANET;UNIPROT
672BRCA1C0677776Hereditary Breast and Ovarian Cancer Syndrome0.462362980016374BEFREE;CTD_human;ORPHANET
672BRCA1C1458155Mammary Neoplasms0.412747542568915BEFREE;CTD_human;GAD;LHGDN
672BRCA1C0919267ovarian neoplasm0.382527596305474BEFREE;CTD_human;GAD;LHGDN
672BRCA1C1140680Malignant neoplasm of ovary0.36BEFREE;GAD;UNIPROT
672BRCA1C0346153Breast Cancer, Familial0.281803069160874BEFREE;GAD;ORPHANET
672BRCA1C0678222Breast Carcinoma0.28BEFREE;HPO
672BRCA1C0024667Animal Mammary Neoplasms0.28CTD_human;GAD
672BRCA1C0033578Prostatic Neoplasms0.225215763906712BEFREE;CTD_human;GAD;LHGDN
672BRCA1C0030297Pancreatic Neoplasm0.222315024592644CTD_human;GAD;LHGDN
672BRCA1C0376628Chromosome Breakage0.204814057046576CTD_human;GAD
672BRCA1C0007621Neoplastic Cell Transformation0.202407028523288CTD_human;GAD
672BRCA1C2931456Prostate cancer, familial0.201648360705279BEFREE;ORPHANET
672BRCA1C0011570Mental Depression0.201098907136852BEFREE;PSYGENET
672BRCA1C0011581Depressive disorder0.201098907136852BEFREE;PSYGENET
672BRCA1C1514428Primary Peritoneal Carcinoma0.200824180352639BEFREE;ORPHANET
672BRCA1C2931038Pancreatic carcinoma, familial0.200549453568426BEFREE;ORPHANET
672BRCA1C0010606Adenoid Cystic Carcinoma0.200274726784213BEFREE;CTD_human
672BRCA1C0031154Peritonitis0.200274726784213BEFREE;HPO
672BRCA1C0000731Abdomen distended0.2HPO
672BRCA1C0000737Abdominal Pain0.2HPO
672BRCA1C0009806Constipation0.2HPO
672BRCA1C0024668Mammary Neoplasms, Experimental0.2CTD_human
672BRCA1C0026636Mouth Diseases0.2CTD_human
672BRCA1C0027498Nausea and vomiting0.2HPO
672BRCA1C0036341Schizophrenia0.2PSYGENET
672BRCA1C0237326Dyschezia0.2HPO
672BRCA1C2675520BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 20.2ORPHANET
672BRCA1C3150659BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 30.2ORPHANET
672BRCA1C0029925Ovarian Carcinoma0.082407028523288BEFREE;GAD
672BRCA1C0020538Hypertensive disease0.08RGD
672BRCA1C0376358Malignant neoplasm of prostate0.045708188651085BEFREE;GAD
672BRCA1C0596263Carcinogenesis0.0395606569266864BEFREE
672BRCA1C1336076Sporadic Breast Carcinoma0.0307693998318672BEFREE
672BRCA1C0677886Epithelial ovarian cancer0.0293302533761718BEFREE;GAD
672BRCA1C3539878Triple Negative Breast Neoplasms0.0271979516370969BEFREE
672BRCA1C0015558Fallopian Tube Neoplasms0.0219891406511178GAD;LHGDN
672BRCA1C0242788Breast Neoplasms, Male0.0181015782718064BEFREE;GAD;LHGDN
672BRCA1C0600139Prostate carcinoma0.0173077874054253BEFREE
672BRCA1C0007124Noninfiltrating Intraductal Carcinoma0.0151738069347267BEFREE;GAD;LHGDN
672BRCA1C0025202melanoma0.0151082944000968BEFREE;GAD;LHGDN
672BRCA1C1527249Colorectal Cancer0.0140237426405616BEFREE;GAD
672BRCA1C0001418Adenocarcinoma0.0130783069756472BEFREE;GAD;LHGDN
672BRCA1C1096616contralateral breast cancer0.0112637981527371BEFREE
672BRCA1C3887505DYSFUNCTION - SKIN DISORDERS0.0104396178000978BEFREE
672BRCA1C0009404Colorectal Neoplasms0.0102798819762035GAD;LHGDN
672BRCA1C0015625Fanconi Anemia0.0101648910158847BEFREE
672BRCA1C0031149Peritoneal Neoplasms0.0099028408773651BEFREE;GAD
672BRCA1C0012860DNA Damage0.009628114093152GAD
672BRCA1C0027626Neoplasm Invasiveness0.009628114093152GAD
672BRCA1C0238033Carcinoma of Male Breast0.0095499249128286BEFREE;GAD
672BRCA1C3469521FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)0.0093407106632454BEFREE
672BRCA1C0242379Malignant neoplasm of lung0.0088694462751426BEFREE;GAD
672BRCA1C0027627Neoplasm Metastasis0.0087912570948192BEFREE
672BRCA1C0242787Malignant neoplasm of male breast0.0087912570948192BEFREE
672BRCA1C1134719Invasive Ductal Breast Carcinoma0.0080452659225033BEFREE;GAD
672BRCA1C0007131Non-Small Cell Lung Carcinoma0.0076923499579668BEFREE
672BRCA1C1333990Hereditary Nonpolyposis Colorectal Cancer0.0063187160369013BEFREE
672BRCA1C0178874Tumor Progression0.0062532035022714BEFREE;GAD
672BRCA1C0032927Precancerous Conditions0.0061876909676415BEFREE;GAD
672BRCA1C1333600Hereditary Malignant Neoplasm0.0060439892526882BEFREE
672BRCA1C0023467Leukemia, Myelocytic, Acute0.00596412134074105BEFREE;GAD;LHGDN
672BRCA1C0853879Invasive carcinoma of breast0.0057692624684751BEFREE
672BRCA1C0024299Lymphoma0.0056382373992153BEFREE;GAD
672BRCA1C0346647Malignant neoplasm of pancreas0.005494535684262BEFREE
672BRCA1C0085183Neoplasms, Second Primary0.00541466777231485BEFREE;GAD;LHGDN
672BRCA1C0005684Malignant neoplasm of urinary bladder0.0053635106150022BEFREE;GAD
672BRCA1C0024305Lymphoma, Non-Hodgkin0.0053635106150022BEFREE;GAD
672BRCA1C0235974Pancreatic carcinoma0.0052198089000489BEFREE
672BRCA1C0476089Endometrial Carcinoma0.005154296365419BEFREE;GAD
672BRCA1C0014170Endometrial Neoplasms0.00513994098810175GAD;LHGDN
672BRCA1C0038356Stomach Neoplasms0.00513994098810175GAD;LHGDN
672BRCA1C0080178Spina Bifida0.00513994098810175GAD;LHGDN
672BRCA1C0006118Brain Neoplasms0.0050887838307891BEFREE;GAD
672BRCA1C0009375Colonic Neoplasms0.004814057046576GAD
672BRCA1C0027643Neoplasm Recurrence, Local0.004814057046576GAD
672BRCA1C0027663Neoplasms, Multiple Primary0.004814057046576GAD
672BRCA1C0027672Neoplastic Syndromes, Hereditary0.004814057046576GAD
672BRCA1C0037286Skin Neoplasms0.004814057046576GAD
672BRCA1C0009402Colorectal Carcinoma0.0046703553316227BEFREE
672BRCA1C0238122Fallopian Tube Carcinoma0.0046703553316227BEFREE
672BRCA1C0281267bilateral breast cancer0.0046703553316227BEFREE
672BRCA1C0007104Female Breast Carcinoma0.0041209017631965BEFREE
672BRCA1C0206701Cystadenocarcinoma, Serous0.0040553892285666BEFREE;GAD
672BRCA1C0024623Malignant neoplasm of stomach0.0035714481947703BEFREE
672BRCA1C0235653Malignant neoplasm of female breast0.0035714481947703BEFREE
672BRCA1C0007137Squamous cell carcinoma0.00355709281745305BEFREE;LHGDN
672BRCA1C0302592Cervix carcinoma0.0035059356601404BEFREE;GAD
672BRCA1C0699791Stomach Carcinoma0.0032967214105572BEFREE
672BRCA1C0023473Myeloid Leukemia, Chronic0.00328236603323995BEFREE;LHGDN
672BRCA1C0017636Glioblastoma0.0032312088759273BEFREE;GAD
672BRCA1C0153579Malignant neoplasm of fallopian tube0.0030219946263441BEFREE
672BRCA1C1710547Unilateral Breast Carcinoma0.0030219946263441BEFREE
672BRCA1C4018978Unilateral Breast Neoplasms0.0030219946263441BEFREE
672BRCA1C0002395Alzheimer's Disease0.00300763924902685BEFREE;LHGDN
672BRCA1C0025958Microcephaly0.00300763924902685BEFREE;LHGDN
672BRCA1C0025322Premature Menopause0.0029564820917142BEFREE;GAD
672BRCA1C0079744Diffuse Large B-Cell Lymphoma0.0029564820917142BEFREE;GAD
672BRCA1C0206692Carcinoma, Lobular0.0029564820917142BEFREE;GAD
672BRCA1C0008626Congenital chromosomal disease0.002747267842131BEFREE
672BRCA1C0153467Malignant tumor of peritoneum0.002747267842131BEFREE
672BRCA1C1854365BREAST CANCER 30.002747267842131BEFREE
672BRCA1C0003130Anoxia0.00273291246481375LHGDN
672BRCA1C0014175Endometriosis0.00273291246481375LHGDN
672BRCA1C0018671Head and Neck Neoplasms0.00273291246481375LHGDN
672BRCA1C0278076Behavioral tic0.00273291246481375LHGDN
672BRCA1C0019829Hodgkin Disease0.0026817553075011BEFREE;GAD
672BRCA1C0024301Lymphoma, Follicular0.0026817553075011BEFREE;GAD
672BRCA1C0007117Basal cell carcinoma0.002407028523288GAD
672BRCA1C0008625Chromosome Aberrations0.002407028523288GAD
672BRCA1C0017638Glioma0.002407028523288GAD
672BRCA1C0024117Chronic Obstructive Airway Disease0.002407028523288GAD
672BRCA1C0024232Lymphatic Metastasis0.002407028523288GAD
672BRCA1C0025312Meningomyelocele0.002407028523288GAD
672BRCA1C0026277Mixed Salivary Gland Tumor0.002407028523288GAD
672BRCA1C0026769Multiple Sclerosis0.002407028523288GAD
672BRCA1C0027404Narcolepsy0.002407028523288GAD
672BRCA1C0029928Ovarian Diseases0.002407028523288GAD
672BRCA1C0036095Salivary Gland Neoplasms0.002407028523288GAD
672BRCA1C0040336Tobacco Use Disorder0.002407028523288GAD
672BRCA1C0042162Uveal Neoplasms0.002407028523288GAD
672BRCA1C0948698Coronary spastic angina0.002407028523288GAD
672BRCA1C1512981Mammary Tumorigenesis0.0021978142737048BEFREE
672BRCA1C0686619Secondary malignant neoplasm of lymph node0.0019230874894917BEFREE
672BRCA1C0815107psychological distress0.0019230874894917BEFREE
672BRCA1C1176475Ductal Carcinoma0.0019230874894917BEFREE
672BRCA1C3839280High grade serous carcinoma0.0019230874894917BEFREE
672BRCA1C0007102Malignant tumor of colon0.0019230874894917BEFREE
672BRCA1C0040997Trigeminal Neuralgia0.0019230874894917BEFREE
672BRCA1C0278488Carcinoma breast stage IV0.0019230874894917BEFREE
672BRCA1C0424295Hyperactive behavior0.0016483607052786BEFREE
672BRCA1C0699790Colon Carcinoma0.0016483607052786BEFREE
672BRCA1C0281361Adenocarcinoma of pancreas0.0013736339210655BEFREE
672BRCA1C0334359Papillary serous cystadenocarcinoma0.0013736339210655BEFREE
672BRCA1C0684249Carcinoma of lung0.0013736339210655BEFREE
672BRCA1C0699889Malignant Female Reproductive System Neoplasm0.0013736339210655BEFREE
672BRCA1C1261473Sarcoma0.0013736339210655BEFREE
672BRCA1C1306460Primary malignant neoplasm of lung0.0013736339210655BEFREE
672BRCA1C1883486Uterine Corpus Cancer0.0013736339210655BEFREE
672BRCA1C0004135Ataxia Telangiectasia0.0013736339210655BEFREE
672BRCA1C0007103Malignant neoplasm of endometrium0.0013736339210655BEFREE
672BRCA1C0003467Anxiety0.0010989071368524BEFREE
672BRCA1C0003469Anxiety Disorders0.0010989071368524BEFREE
672BRCA1C0154084Stage 0 Breast Carcinoma0.0010989071368524BEFREE
672BRCA1C0677898invasive cancer0.0010989071368524BEFREE
672BRCA1C1335302Pancreatic Ductal Adenocarcinoma0.0010989071368524BEFREE
672BRCA1C3642345Luminal A Breast Carcinoma0.0010989071368524BEFREE
672BRCA1C0332996Persistent embryonic structure0.0008241803526393BEFREE
672BRCA1C0398791Nijmegen Breakage Syndrome0.0008241803526393BEFREE
672BRCA1C0553665Skin endocrine disorder0.0008241803526393BEFREE
672BRCA1C0860580Medullary carcinoma of breast0.0008241803526393BEFREE
672BRCA1C0948303Carcinoma of peritoneum0.0008241803526393BEFREE
672BRCA1C1168401Squamous cell carcinoma of the head and neck0.0008241803526393BEFREE
672BRCA1C1266082Atypical medullary carcinoma0.0008241803526393BEFREE
672BRCA1C4048328cervical cancer0.0008241803526393BEFREE
672BRCA1C0005695Bladder Neoplasm0.0008241803526393BEFREE
672BRCA1C0007847Malignant tumor of cervix0.0008241803526393BEFREE
672BRCA1C0018553Hamartoma Syndrome, Multiple0.0008241803526393BEFREE
672BRCA1C0023418leukemia0.0008241803526393BEFREE
672BRCA1C0023434Chronic Lymphocytic Leukemia0.0008241803526393BEFREE
672BRCA1C0033036Atrial Premature Complexes0.0008241803526393BEFREE
672BRCA1C0035335Retinoblastoma0.0008241803526393BEFREE
672BRCA1C0085390Li-Fraumeni Syndrome0.0008241803526393BEFREE
672BRCA1C0086132Depressive Symptoms0.0008241803526393BEFREE
672BRCA1C0278689Ovarian epithelial cancer recurrent0.0008241803526393BEFREE
672BRCA1C0279626Squamous cell carcinoma of esophagus0.0008241803526393BEFREE
672BRCA1C0005859Bloom Syndrome0.0005494535684262BEFREE
672BRCA1C0007133Carcinoma, Papillary0.0005494535684262BEFREE
672BRCA1C0010674Cystic Fibrosis0.0005494535684262BEFREE
672BRCA1C0010709Cyst0.0005494535684262BEFREE
672BRCA1C0011849Diabetes Mellitus0.0005494535684262BEFREE
672BRCA1C0014859Esophageal Neoplasms0.0005494535684262BEFREE
672BRCA1C0016034Breast Fibrocystic Disease0.0005494535684262BEFREE
672BRCA1C0018801Heart failure0.0005494535684262BEFREE
672BRCA1C0018802Congestive heart failure0.0005494535684262BEFREE
672BRCA1C0019187Hepatitis, Alcoholic0.0005494535684262BEFREE
672BRCA1C0023269leiomyosarcoma0.0005494535684262BEFREE
672BRCA1C0027708Nephroblastoma0.0005494535684262BEFREE
672BRCA1C0027819Neuroblastoma0.0005494535684262BEFREE
672BRCA1C0027831Neurofibromatosis 10.0005494535684262BEFREE
672BRCA1C0032580Adenomatous Polyposis Coli0.0005494535684262BEFREE
672BRCA1C0041296Tuberculosis0.0005494535684262BEFREE
672BRCA1C0041408Turner Syndrome0.0005494535684262BEFREE
672BRCA1C0042373Vascular Diseases0.0005494535684262BEFREE
672BRCA1C0079588Ichthyosis, X-Linked0.0005494535684262BEFREE
672BRCA1C0085215Ovarian Failure, Premature0.0005494535684262BEFREE
672BRCA1C0151779Cutaneous Melanoma0.0005494535684262BEFREE
672BRCA1C0152018Esophageal carcinoma0.0005494535684262BEFREE
672BRCA1C0153567Uterine Cancer0.0005494535684262BEFREE
672BRCA1C0162429Malnutrition0.0005494535684262BEFREE
672BRCA1C0175754Agenesis of corpus callosum0.0005494535684262BEFREE
672BRCA1C0279563Lobular carcinoma in situ of breast0.0005494535684262BEFREE
672BRCA1C0280220stage, ovarian epithelial cancer0.0005494535684262BEFREE
672BRCA1C0282160Aplasia Cutis Congenita0.0005494535684262BEFREE
672BRCA1C0334381Non-infiltrating lobular carcinoma0.0005494535684262BEFREE
672BRCA1C0347176Carcinoma in situ of fallopian tube0.0005494535684262BEFREE
672BRCA1C0349566Squamous cell carcinoma of tongue0.0005494535684262BEFREE
672BRCA1C0546837Malignant neoplasm of esophagus0.0005494535684262BEFREE
672BRCA1C0699885Carcinoma of bladder0.0005494535684262BEFREE
672BRCA1C0700095Central neuroblastoma0.0005494535684262BEFREE
672BRCA1C0751366Radiation-Induced Cancer0.0005494535684262BEFREE
672BRCA1C0751416Pelvic Cancer0.0005494535684262BEFREE
672BRCA1C0862506Borderline ovarian tumour0.0005494535684262BEFREE
672BRCA1C0878500Intraepithelial Neoplasia0.0005494535684262BEFREE
672BRCA1C0940937precancerous lesions0.0005494535684262BEFREE
672BRCA1C1334274Invasive Carcinoma0.0005494535684262BEFREE
672BRCA1C1335177Ovarian Serous Adenocarcinoma0.0005494535684262BEFREE
672BRCA1C1709246Non-Neoplastic Disorder0.0005494535684262BEFREE
672BRCA1C2675080Li-Fraumeni-Like Syndrome0.0005494535684262BEFREE
672BRCA1C2717836Steroid Sulfatase Deficiency Disease0.0005494535684262BEFREE
672BRCA1C2986665Early-Stage Breast Carcinoma0.0005494535684262BEFREE
672BRCA1C3274709Contralateral Breast Carcinoma0.0005494535684262BEFREE
672BRCA1C3642254High Grade Ovarian Serous Adenocarcinoma0.0005494535684262BEFREE
672BRCA1C3642346Luminal B Breast Carcinoma0.0005494535684262BEFREE
672BRCA1C0280100solid tumor0.0002747267842131BEFREE
672BRCA1C0280631Leiomyosarcoma of uterus0.0002747267842131BEFREE
672BRCA1C0332875Congenital webbing0.0002747267842131BEFREE
672BRCA1C0333307Superficial ulcer0.0002747267842131BEFREE
672BRCA1C0333463Senile Plaques0.0002747267842131BEFREE
672BRCA1C0338656Impaired cognition0.0002747267842131BEFREE
672BRCA1C0345967Malignant mesothelioma0.0002747267842131BEFREE
672BRCA1C0346156Benign neoplasm of breast0.0002747267842131BEFREE
672BRCA1C0346976Secondary malignant neoplasm of pancreas0.0002747267842131BEFREE
672BRCA1C0346990Carcinomatosis of peritoneal cavity0.0002747267842131BEFREE
672BRCA1C0375023Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site0.0002747267842131BEFREE
672BRCA1C0376545Hematologic Neoplasms0.0002747267842131BEFREE
672BRCA1C0442876Occult carcinoma0.0002747267842131BEFREE
672BRCA1C0496779Malignant neoplasm of appendix0.0002747267842131BEFREE
672BRCA1C0521158Recurrent tumor0.0002747267842131BEFREE
672BRCA1C0524620Metabolic Syndrome X0.0002747267842131BEFREE
672BRCA1C0549379Recurrent Carcinoma0.0002747267842131BEFREE
672BRCA1C0558353Tongue Carcinoma0.0002747267842131BEFREE
672BRCA1C0595989Carcinoma of larynx0.0002747267842131BEFREE
672BRCA1C0598798Lymphoid neoplasm0.0002747267842131BEFREE
672BRCA1C0598935Tumor Initiation0.0002747267842131BEFREE
672BRCA1C0677660Emotional problems0.0002747267842131BEFREE
672BRCA1C0677932Progressive Neoplastic Disease0.0002747267842131BEFREE
672BRCA1C0740421Postsurgical menopause0.0002747267842131BEFREE
672BRCA1C0741682breast cancer (non-specific) premenopausal0.0002747267842131BEFREE
672BRCA1C0751690Malignant Peripheral Nerve Sheath Tumor0.0002747267842131BEFREE
672BRCA1C0751887Medullary Neoplasms0.0002747267842131BEFREE
672BRCA1C0848332Spots on skin0.0002747267842131BEFREE
672BRCA1C0853662Oestrogen deficiency0.0002747267842131BEFREE
672BRCA1C0856169Endothelial dysfunction0.0002747267842131BEFREE
672BRCA1C0858252breast adenocarcinoma0.0002747267842131BEFREE
672BRCA1C0920506Environment-Related Malignant Neoplasm0.0002747267842131BEFREE
672BRCA1C0948216ovarian adenocarcinoma0.0002747267842131BEFREE
672BRCA1C0948750Salivary gland carcinoma0.0002747267842131BEFREE
672BRCA1C1142025Stage IV Esophageal Squamous Cell Carcinoma0.0002747267842131BEFREE
672BRCA1C1257930Mammary Carcinoma, Human0.0002747267842131BEFREE
672BRCA1C1262091Lymphocytic infiltration0.0002747267842131BEFREE
672BRCA1C1290375Mesothelioma (malignant, clinical disorder) (disorder)0.0002747267842131BEFREE
672BRCA1C1292769Precursor B-cell lymphoblastic leukemia0.0002747267842131BEFREE
672BRCA1C1302790Congenital malformation syndrome0.0002747267842131BEFREE
672BRCA1C1306050Primary malignant neoplasm of appendix0.0002747267842131BEFREE
672BRCA1C1332347Atypical Ductal Breast Hyperplasia0.0002747267842131BEFREE
672BRCA1C1333992Hereditary Ovarian Carcinoma0.0002747267842131BEFREE
672BRCA1C1334411Locally Metastatic Malignant Neoplasm0.0002747267842131BEFREE
672BRCA1C1334708Metaplastic breast carcinoma0.0002747267842131BEFREE
672BRCA1C1334753Breast Microglandular Adenosis0.0002747267842131BEFREE
672BRCA1C1336735Therapy-Related Acute Myeloid Leukemia0.0002747267842131BEFREE
672BRCA1C1337013Differentiated Thyroid Gland Carcinoma0.0002747267842131BEFREE
672BRCA1C1368683Epithelioma0.0002747267842131BEFREE
672BRCA1C1384494Metastatic Carcinoma0.0002747267842131BEFREE
672BRCA1C1449563Cardiomyopathy, Familial Idiopathic0.0002747267842131BEFREE
672BRCA1C1512127HER2 gene amplification0.0002747267842131BEFREE
672BRCA1C1519680Tumor Immunity0.0002747267842131BEFREE
672BRCA1C1619738Immune Reconstitution Inflammatory Syndrome0.0002747267842131BEFREE
672BRCA1C1835817FANCONI ANEMIA, COMPLEMENTATION GROUP N0.0002747267842131BEFREE
672BRCA1C1836860FANCONI ANEMIA, COMPLEMENTATION GROUP J0.0002747267842131BEFREE
672BRCA1C1855840HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME0.0002747267842131BEFREE
672BRCA1C1855900HYPERTRICHOSIS, CONGENITAL GENERALIZED0.0002747267842131BEFREE
672BRCA1C1856689FRIEDREICH ATAXIA 10.0002747267842131BEFREE
672BRCA1C1861906Breast Cancer, Familial Male0.0002747267842131BEFREE
672BRCA1C1862382SVEINSSON CHORIORETINAL ATROPHY0.0002747267842131BEFREE
672BRCA1C1866260Peroxisome Biogenesis Disorder, Complementation Group H0.0002747267842131BEFREE
672BRCA1C1961099Precursor T-Cell Lymphoblastic Leukemia-Lymphoma0.0002747267842131BEFREE
672BRCA1C2216695malignant neoplasm of breast stage I0.0002747267842131BEFREE
672BRCA1C2216702malignant neoplasm of breast staging0.0002747267842131BEFREE
672BRCA1C2239176Liver carcinoma0.0002747267842131BEFREE
672BRCA1C2362324Pediatric Obesity0.0002747267842131BEFREE
672BRCA1C2677792Riddle Syndrome0.0002747267842131BEFREE
672BRCA1C2745900Promyelocytic leukemia0.0002747267842131BEFREE
672BRCA1C2931822Nasopharyngeal carcinoma0.0002747267842131BEFREE
672BRCA1C2945695Limb ischemia0.0002747267842131BEFREE
672BRCA1C2986662Multifocal Breast Carcinoma0.0002747267842131BEFREE
672BRCA1C3146271Stage III Breast Cancer AJCC v70.0002747267842131BEFREE
672BRCA1C3160738FANCONI ANEMIA, COMPLEMENTATION GROUP D20.0002747267842131BEFREE
672BRCA1C3160739FANCONI ANEMIA, COMPLEMENTATION GROUP E0.0002747267842131BEFREE
672BRCA1C3250443MYOTONIC DYSTROPHY 10.0002747267842131BEFREE
672BRCA1C3539781Progressive cGVHD0.0002747267842131BEFREE
672BRCA1C3549742Breast cancer, lobular0.0002747267842131BEFREE
672BRCA1C3647143Secondary malignant neoplasm of ovary0.0002747267842131BEFREE
672BRCA1C3887461Head and Neck Carcinoma0.0002747267842131BEFREE
672BRCA1C3887524Skin Erosion0.0002747267842131BEFREE
672BRCA1C3888194MIXED LINEAGE LEUKEMIA0.0002747267842131BEFREE
672BRCA1C3899989Autosomal Dominant Disorder0.0002747267842131BEFREE
672BRCA1C4016282BREAST CANCER, SOMATIC0.0002747267842131BEFREE
672BRCA1C0001430Adenoma0.0002747267842131BEFREE
672BRCA1C0002453Amenorrhea0.0002747267842131BEFREE
672BRCA1C0002726Amyloidosis0.0002747267842131BEFREE
672BRCA1C0002736Amyotrophic Lateral Sclerosis0.0002747267842131BEFREE
672BRCA1C0002793Anaplasia0.0002747267842131BEFREE
672BRCA1C0002895Anemia, Sickle Cell0.0002747267842131BEFREE
672BRCA1C0003504Aortic Valve Insufficiency0.0002747267842131BEFREE
672BRCA1C0003850Arteriosclerosis0.0002747267842131BEFREE
672BRCA1C0004153Atherosclerosis0.0002747267842131BEFREE
672BRCA1C0006413Burkitt Lymphoma0.0002747267842131BEFREE
672BRCA1C0007107Malignant neoplasm of larynx0.0002747267842131BEFREE
672BRCA1C0007114Malignant neoplasm of skin0.0002747267842131BEFREE
672BRCA1C0007134Renal Cell Carcinoma0.0002747267842131BEFREE
672BRCA1C0007138Carcinoma, Transitional Cell0.0002747267842131BEFREE
672BRCA1C0007140Carcinosarcoma0.0002747267842131BEFREE
672BRCA1C0007193Cardiomyopathy, Dilated0.0002747267842131BEFREE
672BRCA1C0007194Hypertrophic Cardiomyopathy0.0002747267842131BEFREE
672BRCA1C0007222Cardiovascular Diseases0.0002747267842131BEFREE
672BRCA1C0008312Primary biliary cirrhosis0.0002747267842131BEFREE
672BRCA1C0009241Cognition Disorders0.0002747267842131BEFREE
672BRCA1C0009319Colitis0.0002747267842131BEFREE
672BRCA1C0009376Colonic Polyps0.0002747267842131BEFREE
672BRCA1C0010633Cystadenoma0.0002747267842131BEFREE
672BRCA1C0011389Dental Plaque0.0002747267842131BEFREE
672BRCA1C0011847Diabetes0.0002747267842131BEFREE
672BRCA1C0013274Patent ductus arteriosus0.0002747267842131BEFREE
672BRCA1C0015230Exanthema0.0002747267842131BEFREE
672BRCA1C0016033Nonproliferative fibrocystic disease0.0002747267842131BEFREE
672BRCA1C0016412Folic Acid Deficiency0.0002747267842131BEFREE
672BRCA1C0017416Genital Neoplasms, Female0.0002747267842131BEFREE
672BRCA1C0018790Cardiac Arrest0.0002747267842131BEFREE
672BRCA1C0019069Hemophilia A0.0002747267842131BEFREE
672BRCA1C0019158Hepatitis0.0002747267842131BEFREE
672BRCA1C0019159Hepatitis A0.0002747267842131BEFREE
672BRCA1C0020179Huntington Disease0.0002747267842131BEFREE
672BRCA1C0020550Hyperthyroidism0.0002747267842131BEFREE
672BRCA1C0021051Immunologic Deficiency Syndromes0.0002747267842131BEFREE
672BRCA1C0021390Inflammatory Bowel Diseases0.0002747267842131BEFREE
672BRCA1C0021670insulinoma0.0002747267842131BEFREE
672BRCA1C0022790Krukenberg Tumor0.0002747267842131BEFREE
672BRCA1C0023051Laryngeal Diseases0.0002747267842131BEFREE
672BRCA1C0023055Laryngeal neoplasm0.0002747267842131BEFREE
672BRCA1C0023267Fibroid Tumor0.0002747267842131BEFREE
672BRCA1C0023474Leukemia, Myeloid, Chronic-Phase0.0002747267842131BEFREE
672BRCA1C0023531Leukoplakia0.0002747267842131BEFREE
672BRCA1C0025286Meningioma0.0002747267842131BEFREE
672BRCA1C0025500Mesothelioma0.0002747267842131BEFREE
672BRCA1C0026654Moyamoya Disease0.0002747267842131BEFREE
672BRCA1C0026684Mucocele of appendix0.0002747267842131BEFREE
672BRCA1C0026764Multiple Myeloma0.0002747267842131BEFREE
672BRCA1C0027051Myocardial Infarction0.0002747267842131BEFREE
672BRCA1C0027832Neurofibromatosis 20.0002747267842131BEFREE
672BRCA1C0028754Obesity0.0002747267842131BEFREE
672BRCA1C0030312Pancytopenia0.0002747267842131BEFREE
672BRCA1C0031269Peutz-Jeghers Syndrome0.0002747267842131BEFREE
672BRCA1C0032285Pneumonia0.0002747267842131BEFREE
672BRCA1C0036690Septicemia0.0002747267842131BEFREE
672BRCA1C0038436Post-Traumatic Stress Disorder0.0002747267842131BEFREE
672BRCA1C0039538Teratoma0.0002747267842131BEFREE
672BRCA1C0040015Thrombasthenia0.0002747267842131BEFREE
672BRCA1C0040411Tongue Neoplasms0.0002747267842131BEFREE
672BRCA1C0041341Tuberous Sclerosis0.0002747267842131BEFREE
672BRCA1C0043119Werner Syndrome0.0002747267842131BEFREE
672BRCA1C0043346Xeroderma Pigmentosum0.0002747267842131BEFREE
672BRCA1C0085669Acute leukemia0.0002747267842131BEFREE
672BRCA1C0085750Adenosis of Breast0.0002747267842131BEFREE
672BRCA1C0086942Rous Sarcoma0.0002747267842131BEFREE
672BRCA1C0153349Malignant neoplasm of tongue0.0002747267842131BEFREE
672BRCA1C0153662Malignant neoplasm of abdomen0.0002747267842131BEFREE
672BRCA1C0153676Secondary malignant neoplasm of lung0.0002747267842131BEFREE
672BRCA1C0205698Undifferentiated carcinoma0.0002747267842131BEFREE
672BRCA1C0205747Familial Atypical Multiple Mole-Melanoma0.0002747267842131BEFREE
672BRCA1C0206247Amyloid Neuropathies0.0002747267842131BEFREE
672BRCA1C0206684Sebaceous Adenocarcinoma0.0002747267842131BEFREE
672BRCA1C0206693Medullary carcinoma0.0002747267842131BEFREE
672BRCA1C0206704Carcinoma, Large Cell0.0002747267842131BEFREE
672BRCA1C0220620Gastrointestinal Carcinoid Tumor0.0002747267842131BEFREE
672BRCA1C0220633Uveal melanoma0.0002747267842131BEFREE
672BRCA1C0220650Metastatic malignant neoplasm to brain0.0002747267842131BEFREE
672BRCA1C0221228Comedone0.0002747267842131BEFREE
672BRCA1C0231341Premature aging syndrome0.0002747267842131BEFREE
672BRCA1C0233514Abnormal behavior0.0002747267842131BEFREE
672BRCA1C0233794Memory impairment0.0002747267842131BEFREE
672BRCA1C0235162Difficulty sleeping0.0002747267842131BEFREE
672BRCA1C0237053adnexal lesion0.0002747267842131BEFREE
672BRCA1C0238463Papillary thyroid carcinoma0.0002747267842131BEFREE
672BRCA1C0243026Sepsis0.0002747267842131BEFREE
672BRCA1C0260037Multiple tumors0.0002747267842131BEFREE
672BRCA1C0265202Seckel syndrome0.0002747267842131BEFREE
672BRCA1C0268141Xeroderma pigmentosum, group G0.0002747267842131BEFREE
672BRCA1C0275524Coinfection0.0002747267842131BEFREE
672BRCA1C0278485Carcinoma breast stage I0.0002747267842131BEFREE
672BRCA1C0278486Breast cancer stage II0.0002747267842131BEFREE
672BRCA1C0278487Stage III Breast Cancer AJCC v60.0002747267842131BEFREE
672BRCA1C0278504Non-small cell lung cancer stage I0.0002747267842131BEFREE
672BRCA1C0278601Inflammatory Breast Carcinoma0.0002747267842131BEFREE
672BRCA1C0278704Malignant Childhood Neoplasm0.0002747267842131BEFREE
672BRCA1C0278987Non-small cell lung cancer metastatic0.0002747267842131BEFREE
672BRCA1C0279565Invasive Lobular Breast Carcinoma0.0002747267842131BEFREE
672BRCA1C0279661Acinar cell carcinoma of pancreas0.0002747267842131BEFREE